Eric C. Darby, MD, FACS

Dr. Eric Darby Designated as a Center of Excellence for GreenLight™ Laser Therapy

PRESS RELEASE

 
TPMG Logo

Contact:
Terri Reedy
terri.reedy@tpmgpc.com
757.232.8843

 

Dr. Eric Darby Designated as a Center of Excellence for GreenLight™ Laser Therapy, a Treatment for Benign Prostatic Hyperplasia (BPH), or Enlarged Prostate

 

Center of Excellence Recognizes High Degree of Experience with New Technology

 

Congratulations Dr. Darby and team on becoming the only GreenLightCenter of Excellence on the Peninsula! This new program was designed to formally recognize and promote physicians who have achieved a high degree of expertise with GreenLight Laser Therapy. The ultimate goal is to help men suffering from LUTS/BPH to quickly find highly skilled Urologists in their specific area via the www.treatmybph.com “Find a Specialist” tool to receive the highest quality of care and best possible clinical outcomes. See below:

 

Newport News, VA—November 3, 2020Boston Scientific today announced that Dr. Eric Darby has been designated as a Center of Excellence for GreenLight™ Laser Therapy treatment – a minimally invasive outpatient procedure for men looking to treat their benign prostatic hyperplasia (BPH), not just the symptoms. GreenLight™ Therapy can help provide immediate relief from enlarged prostate symptoms such as frequent urination—especially at night, weak urine flow, urgency and incomplete bladder emptying. In addition, GreenLight Laser Therapy requires no incisions and typically has no overall deleterious impact on sexual function.1 The Center of Excellence designation recognizes Dr. Darby’s high degree of experience with GreenLight™ Laser Therapy and commitment to delivering effective, long-lasting therapy to men suffering from benign prostatic hyperplasia (BPH).1

BPH is a condition in which a man’s prostate enlarges and squeezes the urethra, causing frustrating symptoms such as frequent or urgent urination, a weak or interrupted urine stream, and the need to get up several times a night to urinate. It affects about 50% of men by age 60, and up to 90% of men by age 85.2

“Being designated as a GreenLight™ Center of Excellence is a meaningful recognition for us, as we strive to provide the best possible treatment of urological conditions for patients in the Newport News area,” said Dr. Darby of TPMG Urology. “For years, the primary options for treating BPH were through behavior modifications, medications or invasive surgery. However, medications may not work for everyone and may have undesirable side effects such as dizziness, sexual dysfunction and lower sex drive.3 With GreenLight™ Therapy, we’re able to provide relief of BPH for men who do not want to take medication or want to avoid invasive surgery and implants.”

GreenLight™ Laser Therapy uses laser energy to vaporize the enlarged tissue, creating an open channel for urine to pass through the urethra. In addition to typically experiencing immediate improvements in urine flow, many patients are pleased to know that GreenLight™ typically has no overall deleterious impact on sexual function.1 GreenLight™ Laser therapy is a long-term solution without the need for BPH medication.1

GreenLight™ Therapy is currently being used in many leading urology practices throughout the United States. To date, more than 1 million patients around the world have been successfully treated with GreenLight™ Therapy.4

 

ABOUT TIDEWATER PHYSICIANS MULTISPECIALTY GROUP

Founded in 1992, Tidewater Physicians Multispecialty Group (TPMG) includes more than 220 primary care, specialty physicians and advanced practice clinicians in more than 85 locations throughout southeastern Virginia. TPMG’s mission is to provide superior healthcare that is responsible, physician-directed, and dedicated to keeping patients best interest foremost. The TPMG medical team includes expert physicians, nurse practitioners, physician assistants, nurses, medical assistants, diagnostic staff, and non-clinical staff all working together to provide consistent, compassionate, high-quality medical care. Learn more at www.mytpmg.com.

 

For more information, visit MyTPMG.com or TreatMyBPH.com.


Bachmann A, Tubaro A, Barber N, et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight-XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2015 Feb;193(2):570-8. 

  1. What is BPH? Urology Care Foundation website. https://www.urologyhealth.org/urologic-conditions/benign-prostatic- hyperplasia-(bph).
  2. Roger K, Gilling P. Fast Facts: Benign Prostatic Hyperplasia, 7th edition. Health Press. 2011.
  3. Data on file with Boston Scientific.

 

* Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.

IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural steps for the use of referenced technologies but may not be appropriate for every patient or case. Decisions surrounding patient care depend on the physician’s professional judgment in consideration of all available information for the individual case.

Boston Scientific (BSC) does not promote or encourage the use of its devices outside their approved labeling. Case studies are not necessarily representative of clinical outcomes in all cases as individual results may vary.

 

TreatMyBPH.com is a website sponsored by Boston Scientific.

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

All images are the property of Boston Scientific. All trademarks are the property of their respective owners.

©2020 Boston Scientific Corporation or its affiliates. All rights reserved. URO-826605-AA JUL 2020

 

Media Contact:

Richelle Hammiel

Marketing Content Writer

Richelle.Hammiel@tpmgpc.com